AKT1 and glioblastoma: It exhibits robust anti-proliferative activity in a panel of GBM cell lines including U-87 MG, U-251 MG and U-373 MG via decreased phosphorylation of Akt, GSK3β and p70S6 K, reduced expression of cyclin D, and G1-cycle arrest.